Tags

Type your tag names separated by a space and hit enter

Crystal arthropathies: recognizing and treating "the gouch".
Prim Care. 2010 Dec; 37(4):703-11, v.PC

Abstract

Gout is a common disease and the prevalence is increasing. Chronic hyperuricemia (uric acid serum levels >6.8 mg/dL) is a key feature. Treating to a target uric acid level of 6.0 mg/dL is recommended. In addition to cochicine, probenecid, and allopurinol, feboxostat is a new option for urate-lowering therapy.

Links

Aggregator Full Text
Aggregator Full Text
Publisher Full Text
linkinghub.elsevier.com
journals.elsevierhealth.com

Authors+Show Affiliations

Quillen DM
Department of Community Health and Family Medicine, University of Florida, 625 SW 4th Avenue, Gainesville, FL 32601, USA. quillen@ufl.edu

MeSH

AllopurinolAntimetabolitesChronic DiseaseColchicineFebuxostatGoutGout SuppressantsHumansHyperuricemiaProbenecidThiazolesUric AcidUricosuric Agents

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

21050952

Citation

Quillen, David M.. "Crystal Arthropathies: Recognizing and Treating "the Gouch"." Primary Care, vol. 37, no. 4, 2010, pp. 703-11, v.
Quillen DM. Crystal arthropathies: recognizing and treating "the gouch". Prim Care. 2010;37(4):703-11, v.
Quillen, D. M. (2010). Crystal arthropathies: recognizing and treating "the gouch". Primary Care, 37(4), 703-11, v. https://doi.org/10.1016/j.pop.2010.07.008
Quillen DM. Crystal Arthropathies: Recognizing and Treating "the Gouch". Prim Care. 2010;37(4):703-11, v. PubMed PMID: 21050952.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Crystal arthropathies: recognizing and treating "the gouch". A1 - Quillen,David M, PY - 2010/11/6/entrez PY - 2010/11/6/pubmed PY - 2011/2/18/medline SP - 703-11, v JF - Primary care JO - Prim Care VL - 37 IS - 4 N2 - Gout is a common disease and the prevalence is increasing. Chronic hyperuricemia (uric acid serum levels >6.8 mg/dL) is a key feature. Treating to a target uric acid level of 6.0 mg/dL is recommended. In addition to cochicine, probenecid, and allopurinol, feboxostat is a new option for urate-lowering therapy. SN - 1558-299X UR - https://www.unboundmedicine.com/medline/citation/21050952/Crystal_arthropathies:_recognizing_and_treating_"the_gouch"_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0095-4543(10)00075-8 DB - PRIME DP - Unbound Medicine ER -